Matches in Wikidata for { <http://www.wikidata.org/entity/Q80100535> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q80100535 description "article scientifique publié en 2006" @default.
- Q80100535 description "artículu científicu espublizáu n'agostu de 2006" @default.
- Q80100535 description "im August 2006 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80100535 description "scientific article published on 14 August 2006" @default.
- Q80100535 description "wetenschappelijk artikel" @default.
- Q80100535 description "наукова стаття, опублікована в серпні 2006" @default.
- Q80100535 name "Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression" @default.
- Q80100535 name "Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression" @default.
- Q80100535 type Item @default.
- Q80100535 label "Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression" @default.
- Q80100535 label "Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression" @default.
- Q80100535 prefLabel "Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression" @default.
- Q80100535 prefLabel "Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression" @default.
- Q80100535 P1433 Q80100535-BCFCDFAE-3816-4599-856C-BA8F54080150 @default.
- Q80100535 P1476 Q80100535-3D97C975-57E3-4027-9AC9-923687B94B43 @default.
- Q80100535 P2093 Q80100535-2839A722-1845-451D-B8B9-FC949D49EB08 @default.
- Q80100535 P2093 Q80100535-7B6FD4D4-52D0-4C99-B91D-8076C07B8429 @default.
- Q80100535 P2093 Q80100535-C1911FCF-0832-4934-B372-581AA1F2DAB4 @default.
- Q80100535 P304 Q80100535-68290CB1-1564-49A4-A24F-18944B5ECA0F @default.
- Q80100535 P31 Q80100535-F29910CC-4732-4431-A550-E2C8EEB23858 @default.
- Q80100535 P356 Q80100535-821E7F2D-72FD-4FFB-A850-EBBD3BC291C1 @default.
- Q80100535 P433 Q80100535-97E98804-55B7-46AD-9624-A8C5DA20F35C @default.
- Q80100535 P478 Q80100535-106BB9B4-2D5C-4C19-932D-75F7132F58AA @default.
- Q80100535 P50 Q80100535-75734B9D-D900-4FD7-A864-C873AC8F09E3 @default.
- Q80100535 P50 Q80100535-D749691C-FF4B-408D-B2E6-5F57760CAD94 @default.
- Q80100535 P577 Q80100535-0C5FD196-BDDD-4140-B0E8-C7B631B9C854 @default.
- Q80100535 P698 Q80100535-8803CA10-F75A-49AC-BC30-E080D81D1284 @default.
- Q80100535 P921 Q80100535-076303B6-82F6-4A52-948D-FCDC071ADD8D @default.
- Q80100535 P921 Q80100535-6E4BD6DD-1722-498B-9170-4B91A2D30373 @default.
- Q80100535 P356 J.MEHY.2006.06.027 @default.
- Q80100535 P698 16905272 @default.
- Q80100535 P1433 Q5558534 @default.
- Q80100535 P1476 "Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression" @default.
- Q80100535 P2093 "Fatih Karaahmet" @default.
- Q80100535 P2093 "Mehmet Ozen" @default.
- Q80100535 P2093 "Nilufer Bulut" @default.
- Q80100535 P304 "235" @default.
- Q80100535 P31 Q13442814 @default.
- Q80100535 P356 "10.1016/J.MEHY.2006.06.027" @default.
- Q80100535 P433 "1" @default.
- Q80100535 P478 "68" @default.
- Q80100535 P50 Q41835237 @default.
- Q80100535 P50 Q87657419 @default.
- Q80100535 P577 "2006-08-14T00:00:00Z" @default.
- Q80100535 P698 "16905272" @default.
- Q80100535 P921 Q412616 @default.
- Q80100535 P921 Q5311598 @default.